Genmab A/S banner

Genmab A/S
NASDAQ:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
NASDAQ:GMAB
Watchlist
Price: 34.01 USD -1.56% Market Closed
Market Cap: $21.6B

Wall St Price Targets

GMAB Price Forecast
Based on 21 analysts

+13% Upside
from $34.01 today

Genmab A/S (GMAB)’s 12-month stock price forecast through October 2027 has a consensus target of $38.56, implying 13% upside. The forecast is based on price targets from 21 Wall Street analysts.

GMAB Analyst Rating
Based on 11 analysts

avg. 4.73 of 5
Strong buy
9 82%
Buy
1 9%
Hold
1 9%
Sell
0 0%
Strong sell
0 0%

Analysts rate GMAB Strong buy, with 10 of 11 recommending Buy or Strong buy.

Genmab A/S Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is GMAB's stock price target?
Price Target
38.56 USD

According to Wall Street analysts, the average 1-year price target for GMAB is 38.56 USD with a low forecast of 21.38 USD and a high forecast of 63.51 USD.

What is the Revenue forecast for Genmab A/S?
Projected CAGR
10%

Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 8 years is 10%.

What is the Gross Profit forecast for Genmab A/S?
Projected CAGR
7%

The compound annual growth rate for Gross Profit over the next 8 years is 7%.

What is the Operating Income forecast for Genmab A/S?
Projected CAGR
10%

The compound annual growth rate for Operating Income over the next 8 years is 10%.

What is the Pre-Tax Income forecast for Genmab A/S?
Projected CAGR
20%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 20%.

What is the Net Income forecast for Genmab A/S?
Projected CAGR
12%

The compound annual growth rate for Net Income over the next 8 years is 12%.

Back to Top